Dr. Schär, the leading Italian company specializing in gluten-free and special nutrition, reported a strong financial performance for 2024, closing the year with a global turnover of EUR624m, an 11% increase over the previous year.
Growth was evident across all regions, with approximately 70% of revenue stemming from the company’s foreign subsidiaries. Italy, Germany, and the United States emerged as the best-performing markets, while the United Kingdom, home to the company’s headquarters in Warrington and a production facility in Glasgow, remained a key strategic region.
The latest financial results reaffirm Dr. Schär’s robust market position, bolstered by a significant EUR45m investment in innovation and expansion. The company’s double-digit growth was primarily driven by its Schär brand and a strategy focused on internationalization and the enhancement of local production—critical components of its business model.
“These results make us proud and underline the validity of our business model, highlighting the excellent growth potential of our company. During the year, we strengthened our global presence through targeted strategic operations, including implementing the acquisition of Hero’s gluten-free business in the Nordic countries, which reinforced our presence and increased our market share. The expansion of our production capacity in a key market such as Spain and the consolidation and expansion of the US sites into the existing Swedesboro site should also be mentioned,” said Hannes Berger, CEO of Dr. Schär.
Innovation remained a central theme in 2024, marked by the launch of the Mikara brand and its flagship product, Mikara Shake—a nutritional solution designed to support the dietary management of rheumatoid arthritis patients. This development represents a significant milestone in Dr. Schär’s evolution, opening new growth opportunities in the specialized nutrition segment.
Alongside its financial success, the company has made notable strides in sustainability. Later this year, Dr. Schär is set to release its second Sustainability Report, aligned with the European Sustainability Reporting Standards (ESRS), documenting progress over the 2023-2024 period. Among key achievements, 70% of its product portfolio now features recyclable packaging, while plastic consumption for Schär product packaging has been reduced by 15%.
“In an ever-changing market, our priority is to consolidate our core brand by strengthening our position in current markets and expanding into new strategic areas,” Berger concluded. “We aim for dynamic growth through investments in innovation, digitalization, and sustainability. Our goal is to offer consumers increasingly advanced nutritional solutions, expanding our global presence and maintaining the high standards of excellence that set us apart from other players in the market.”
Find out more at: https://www.drschaer.com/